SofWave Medical Ltd. Appoints James Bartholomeusz as Chief Innovation Officer - Marketscreener.com
| SOFW Stock | 1,719 17.00 1.00% |
About 51% of Sofwave Medical's investor base is interested to short. The analysis of current outlook of investing in Sofwave Medical suggests that many traders are impartial regarding Sofwave Medical's prospects. The current market sentiment, together with Sofwave Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Sofwave Medical stock news signals to limit their universe of possible portfolio assets.
Sofwave |
SofWave Medical Ltd. Appoints James Bartholomeusz as Chief Innovation Officer Marketscreener.com
Read at news.google.com
 |
Sofwave Medical Fundamental Analysis
We analyze Sofwave Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sofwave Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sofwave Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Sofwave Medical is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Sofwave Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sofwave Medical stock to make a market-neutral strategy. Peer analysis of Sofwave Medical could also be used in its relative valuation, which is a method of valuing Sofwave Medical by comparing valuation metrics with similar companies.
Peers
Sofwave Medical Related Equities
| KVSR | Kvasir Education | 1.92 | ||||
| BEZQ | Bezeq Israeli | 0.75 | ||||
| GKL | Global Knafaim | 0.43 | ||||
| HRON | Hiron Trade | 1.00 | ||||
| RPAC | Rapac Communication | 1.19 | ||||
| BVC | Batm Advanced | 2.95 | ||||
| BYAR | B Yair | 4.44 |
Complementary Tools for Sofwave Stock analysis
When running Sofwave Medical's price analysis, check to measure Sofwave Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sofwave Medical is operating at the current time. Most of Sofwave Medical's value examination focuses on studying past and present price action to predict the probability of Sofwave Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sofwave Medical's price. Additionally, you may evaluate how the addition of Sofwave Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |